Integrated Multi‐Omics Analysis Identifies HVCN1 as a Potential Mediator in Neuroendocrine–Tumor Interactions in Colorectal Cancer
Comprehensive Physiology · 2026-10 · 16 (5)
DOI: 10.1002/cph4.70250 ↗Kurz gefasst
Fachartikel in der Zeitschrift Comprehensive Physiology, online erschienen am 17.09.2026. Verfasst von Yan Ma und 3 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Objective
To investigate associations among sleep‐related features, neuroendocrine alterations, and colorectal cancer (CRC)‐related molecular programs, and to identify candidate genes involved in hypothalamus–tumor interactions.
Methods
NHANES data were analyzed to assess associations between sleep disorder status and mortality among cancer survivors. An orthotopic MC38 CRC mouse model was used to evaluate sleep–wake and neuroendocrine alterations. Integrative analyses of murine hypothalamic and colorectal tissue transcriptomes, TCGA data, and public hypothalamic single‐cell datasets were performed to identify and characterize candidate genes. HVCN1 knockdown and overexpression were used for functional validation in MC38 cells.
Results
Sleep disorder status was inversely associated with cardiovascular mortality in NHANES cancer survivors (HR = 0.47, 95% CI: 0.29–0.74, p = 0.001), but not with all‐cause or cancer‐specific mortality. Tumor‐bearing mice exhibited sleep fragmentation‐like changes with increased corticosterone and norepinephrine levels. Transcriptomic integration identified 28 shared genes between hypothalamic and colorectal tissues, including HVCN1. TCGA analysis identified a sleep disturbance‐related CRC subtype with poorer survival, while single‐cell analysis revealed cell‐type‐dependent expression of HVCN1 across hypothalamic populations. HVCN1 was upregulated in hypothalamic and tumor tissues, and its overexpression promoted MC38 cell proliferation, migration, and invasion, whereas knockdown produced opposite effects.
Conclusion
Tumor‐bearing status is associated with coordinated sleep–wake, neuroendocrine, and molecular alterations. HVCN1 is a candidate component of the hypothalamus–tumor interaction framework and regulates aggressive CRC cell behaviors in vitro, while its proposed pH‐regulatory mechanism requires further validation.
Zitieren
APA
Ma, Y., Ding, Y., Li, T., & Miao, C. (2026). Integrated Multi‐Omics Analysis Identifies HVCN1 as a Potential Mediator in Neuroendocrine–Tumor Interactions in Colorectal Cancer. Comprehensive Physiology, 16(5). https://doi.org/10.1002/cph4.70250
Vancouver
Ma Y, Ding Y, Li T, Miao C. Integrated Multi‐Omics Analysis Identifies HVCN1 as a Potential Mediator in Neuroendocrine–Tumor Interactions in Colorectal Cancer. Comprehensive Physiology. 2026;16(5). doi:10.1002/cph4.70250
BibTeX
@article{Ma2026,
author = {Ma, Yan and Ding, Yan and Li, Ting and Miao, Changhong},
title = {Integrated Multi‐Omics Analysis Identifies HVCN1 as a Potential Mediator in Neuroendocrine–Tumor Interactions in Colorectal Cancer},
journal = {Comprehensive Physiology},
year = {2026},
volume = {16},
number = {5},
doi = {10.1002/cph4.70250}
}
EUVIMED